FDA NDC Directory · JSON-LD · Markdown

Elrexfio

NDC 0069-2522 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameelranatamab-bcmm
Labeler / ManufacturerPfizer Laboratories Div Pfizer Inc
Marketing categoryBiologic License Application · App BLA761345
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsELRANATAMAB (44 mg/1.1mL)
Marketing started20230815
Package count1

External sources

Source: openFDA. Public-domain (CC0).